9 March 2010, 4:51 am
iBio, Inc., Newark, announced that it has agreed in principle to license its technology, the iBioLaunch platform, and provide technology transfer services to G-Con, LLC, a private Texas company, and its affiliates, for the development and manufacture of plant-expressed influenza vaccines at a new facility being constructed in Bryan, Texas.... Read More »